[Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2026-04-28 Semiconductors
[Disclosure] SK Square (402340) – Decision on Early Acquisition of Treasury Exchangeable Bonds Prior to Maturity / 2026-04-28 Disclosures
[Disclosure] Hanwha Ocean (042660) – Provisional Performance (Consolidated Financial Results) / 2026-04-27 Disclosures
[Disclosure] Hanwha Systems (272210) – Provisional Q1 2026 Revenue at KRW 807.1B, Operating Profit at KRW 34.3B (Net Loss Turns Negative to KRW 95.8B) Disclosures
[Disclosure] Hanwha Systems (272210) – Notice of Investor Relations (IR) Conference for Domestic Institutional Investors on Q1 2026 Earnings Disclosures
[Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea (Correction) / 2026-04-24 Disclosures
[Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P51 (Keytruda Biosimilar) Korea Phase 3 Clinical Trial / 2026-04-24 Disclosures
[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-04-24 Disclosures
[Disclosure] Hanwha Aerospace(012450) – Clarification of Rumors or Reports (Unconfirmed) / 2026-04-24 Disclosures
[Disclosure] Hyundai Motor (005380) – Decision to Acquire Shares in Other Corporation for New R&D and Operational Hub Disclosures
![[Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2026-04-28](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환주성엔지니어링.jpg)
![[Disclosure] SK Square (402340) – Decision on Early Acquisition of Treasury Exchangeable Bonds Prior to Maturity / 2026-04-28](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-SK스퀘어.jpg)
![[Disclosure] Hanwha Ocean (042660) – Provisional Performance (Consolidated Financial Results) / 2026-04-27](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)
![[Disclosure] Hanwha Systems (272210) – Provisional Q1 2026 Revenue at KRW 807.1B, Operating Profit at KRW 34.3B (Net Loss Turns Negative to KRW 95.8B)](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환한화시스템.jpg)
![[Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea (Correction) / 2026-04-24](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
![[Disclosure] Hanwha Aerospace(012450) – Clarification of Rumors or Reports (Unconfirmed) / 2026-04-24](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환-한화에어로스페이스.jpg)
![[Disclosure] Hyundai Motor (005380) – Decision to Acquire Shares in Other Corporation for New R&D and Operational Hub](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-현대차.jpg)